E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/27/2007 in the Prospect News Emerging Markets Daily.

Israel's Elbit Medical to make special interest payment on series D notes

By Angela McDaniels

Seattle, Aug. 27 - Elbit Medical Imaging Ltd. plans to pay a special interest payment of 0.2027% to holders of its series D notes due 2020, according to a company news release.

The payment will be made on Sept. 16 to noteholders of record as of Sept. 2.

The notes have a 5% interest rate linked to the Israeli consumer price index. When the notes were issued on April 1, the company said it would pay an additional 0.5% of interest per year until it published a prospectus for listing the notes on the Tel Aviv Stock Exchange.

The prospectus was published in Israel on Monday, the company said.

Elbit Medical is a subsidiary of Europe Israel (M.M.S) Ltd., a Tel Aviv, Israel-based company engaged primarily in the development of commercial and entertainment centers in central and eastern Europe.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.